Cargando…

Intramyocellular lipid droplets increase with progression of cachexia in cancer patients

BACKGROUND: Intramyocellular lipids are an important source of fuel for mitochondrial fat oxidation and play an important role in intramuscular lipid homeostasis. We hypothesised that due to the phenotype associated with cancer cachexia, there would exist an association between increasing weight los...

Descripción completa

Detalles Bibliográficos
Autores principales: Stephens, Nathan A., Skipworth, Richard J. E., MacDonald, Alisdair J., Greig, Carolyn A., Ross, James A., Fearon, Kenneth C. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3117997/
https://www.ncbi.nlm.nih.gov/pubmed/21766057
http://dx.doi.org/10.1007/s13539-011-0030-x
_version_ 1782206399824003072
author Stephens, Nathan A.
Skipworth, Richard J. E.
MacDonald, Alisdair J.
Greig, Carolyn A.
Ross, James A.
Fearon, Kenneth C. H.
author_facet Stephens, Nathan A.
Skipworth, Richard J. E.
MacDonald, Alisdair J.
Greig, Carolyn A.
Ross, James A.
Fearon, Kenneth C. H.
author_sort Stephens, Nathan A.
collection PubMed
description BACKGROUND: Intramyocellular lipids are an important source of fuel for mitochondrial fat oxidation and play an important role in intramuscular lipid homeostasis. We hypothesised that due to the phenotype associated with cancer cachexia, there would exist an association between increasing weight loss and the number/size of intramyocellular lipid droplets. METHODS: Nineteen cancer patients and 6 controls undergoing surgery were recruited. A rectus abdominis biopsy was performed and processed for transmission electron microscopy (TEM). The number of intramyocellular lipid droplets and lipid droplet diameter were calculated from the TEM images. CT scans, performed as part of patients' routine care, were analysed to determine amount of adipose (intermuscular, visceral and subcutaneous) and muscle tissue. RESULTS: Compared with controls, cancer patients had increased numbers of lipid droplets (mean (SD) 1.8 (1.9) vs. 6.4 (9.1) per ×2,650 field, respectively, p = 0.036). Mean (SD) lipid droplet diameter was also higher in cancer patients compared with controls (0.42 (0.13) vs. 0.24 (0.21) μm, p = 0.015). Mean lipid droplet count correlated positively with the severity of weight loss (R = 0.51, p = 0.025) and negatively with CT-derived measures of intermuscular fat (R = −0.53, p = 0.022) and visceral fat (R = −0.51, p = 0.029). CONCLUSIONS: This study suggests that the number and size of intramyocellular lipid droplets is increased in the presence of cancer and increases further with weight loss/loss of adipose mass in other body compartments.
format Online
Article
Text
id pubmed-3117997
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-31179972011-07-14 Intramyocellular lipid droplets increase with progression of cachexia in cancer patients Stephens, Nathan A. Skipworth, Richard J. E. MacDonald, Alisdair J. Greig, Carolyn A. Ross, James A. Fearon, Kenneth C. H. J Cachexia Sarcopenia Muscle Original Article BACKGROUND: Intramyocellular lipids are an important source of fuel for mitochondrial fat oxidation and play an important role in intramuscular lipid homeostasis. We hypothesised that due to the phenotype associated with cancer cachexia, there would exist an association between increasing weight loss and the number/size of intramyocellular lipid droplets. METHODS: Nineteen cancer patients and 6 controls undergoing surgery were recruited. A rectus abdominis biopsy was performed and processed for transmission electron microscopy (TEM). The number of intramyocellular lipid droplets and lipid droplet diameter were calculated from the TEM images. CT scans, performed as part of patients' routine care, were analysed to determine amount of adipose (intermuscular, visceral and subcutaneous) and muscle tissue. RESULTS: Compared with controls, cancer patients had increased numbers of lipid droplets (mean (SD) 1.8 (1.9) vs. 6.4 (9.1) per ×2,650 field, respectively, p = 0.036). Mean (SD) lipid droplet diameter was also higher in cancer patients compared with controls (0.42 (0.13) vs. 0.24 (0.21) μm, p = 0.015). Mean lipid droplet count correlated positively with the severity of weight loss (R = 0.51, p = 0.025) and negatively with CT-derived measures of intermuscular fat (R = −0.53, p = 0.022) and visceral fat (R = −0.51, p = 0.029). CONCLUSIONS: This study suggests that the number and size of intramyocellular lipid droplets is increased in the presence of cancer and increases further with weight loss/loss of adipose mass in other body compartments. Springer-Verlag 2011-05-31 2011-06 /pmc/articles/PMC3117997/ /pubmed/21766057 http://dx.doi.org/10.1007/s13539-011-0030-x Text en © The Author(s) 2011 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Original Article
Stephens, Nathan A.
Skipworth, Richard J. E.
MacDonald, Alisdair J.
Greig, Carolyn A.
Ross, James A.
Fearon, Kenneth C. H.
Intramyocellular lipid droplets increase with progression of cachexia in cancer patients
title Intramyocellular lipid droplets increase with progression of cachexia in cancer patients
title_full Intramyocellular lipid droplets increase with progression of cachexia in cancer patients
title_fullStr Intramyocellular lipid droplets increase with progression of cachexia in cancer patients
title_full_unstemmed Intramyocellular lipid droplets increase with progression of cachexia in cancer patients
title_short Intramyocellular lipid droplets increase with progression of cachexia in cancer patients
title_sort intramyocellular lipid droplets increase with progression of cachexia in cancer patients
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3117997/
https://www.ncbi.nlm.nih.gov/pubmed/21766057
http://dx.doi.org/10.1007/s13539-011-0030-x
work_keys_str_mv AT stephensnathana intramyocellularlipiddropletsincreasewithprogressionofcachexiaincancerpatients
AT skipworthrichardje intramyocellularlipiddropletsincreasewithprogressionofcachexiaincancerpatients
AT macdonaldalisdairj intramyocellularlipiddropletsincreasewithprogressionofcachexiaincancerpatients
AT greigcarolyna intramyocellularlipiddropletsincreasewithprogressionofcachexiaincancerpatients
AT rossjamesa intramyocellularlipiddropletsincreasewithprogressionofcachexiaincancerpatients
AT fearonkennethch intramyocellularlipiddropletsincreasewithprogressionofcachexiaincancerpatients